Cell signaling news
Here we present recent news items specially selected from Nature, Nature Medicine and Nature Biotechnology.
December 2005
2005:
December |
November |
October |
September |
August |
July |
June |
May |
April |
March |
February |
January
Other years: 2002 | 2003 | 2004 | 2006 | 2007 | 2008 | 2009 | 2010
News | News in brief | News Features
News
Korean scandal will have global fallout
The possibility that Woo Suk Hwang's cloning experiments were faked threatens to undermine confidence in stem-cell research.
Nature (21 December 2005)
| Full Text |
Where now for stem-cell cloners?
Scientists are surveying the wreckage left by the debacle involving stem-cell researcher Woo Suk Hwang after three co-authors on his landmark paper said that it could not be trusted.
Nature (21 December 2005)
| Full Text |
Diet book attacked for its high-protein advice
A growing body of critics say that its high-protein message is not supported by the evidence and question links with meat industry.
Nature (21 December 2005)
| Full Text |
Big money for cancer genomics
NIH announces the first phase of a project that aims to catalogue the genetic changes associated with cancer.
Nature (15 December 2005)
| Full Text |
Pokémon blocks gene name
A cancer research institute has been threatened with legal action by the video-game franchise Pokémon, after one of its researchers borrowed the company's trademark to name an oncogene.
Nature (15 December 2005)
| Full Text |
Journal grows suspicious of Vioxx data
The integrity of a key study of the painkiller Vioxx has been questioned by the New England Journal of Medicine, which published the work in 2000.
Nature (15 December 2005)
| Full Text |
Internet encyclopaedias go head to head
A Nature investigation has found that Jimmy Wales' Wikipedia comes close to Britannica in terms of the accuracy of its science entries.
Nature (15 December 2005)
| Full Text |
UK animal labs still under siege
Construction work restarted last week on a biomedical research facility at the University of Oxford after 18 months of delays because of protests by animal-rights groups.
Nature (8 December 2005)
| Full Text |
Animal-rights militancy exported to US and Europe
Some US and European animal-rights activists are adopting the illegal tactics of extreme UK groups, say police and groups monitoring protest activity.
Nature (8 December 2005)
| Full Text |
TV tests call into question cloner's stem-cell success
Woo Suk Hwang, the cloning researcher who last month admitted lying about the origins of human eggs used in his work, now faces questions about the validity of his scientific data.
Nature (8 December 2005)
| Full Text |
Prospect of stricter timekeeping alarms US biologists
Proposed guidelines for federally funded US researchers, recommending more detailed accounting of how they spend their time, will, if approved, draw howls of protest from labs across the United States.
Nature (8 December 2005)
| Full Text |
Chairman explains Europe's research council
The European Research Council (ERC), to be launched in 2007, will be the first Europe-wide granting agency for basic research and has announced molecular biologist Fotis Kafatos as chairman.
Nature (8 December 2005)
| Full Text |
Europe's restrictive rules strangling clinical research
Since the launch of the European Union Clinical Trials Directive, scientists have warned that the onerous new requirements and added paperwork and costs would hamper trials by academic scientists.
Nature Medicine (December 2005)
| Full Text |
Price of mice to plummet under NIH's new scheme
The US National Institutes of Health (NIH) is set to provide knockout mice to researchers for just $115 each.
Nature Medicine (December 2005)
| Full Text |
Changing ethics rules land Spanish stem cell scientist in hot water
Researcher faces legal action because of new informed consent rules.
Nature Medicine (December 2005)
| Full Text |
GlaxoSmithKline cancer drug threatens Herceptin market
The first targeted therapy for breast cancer could soon face direct competition.
Nature Biotechnology (December 2005)
| Full Text |
Cord blood cell therapy trial suspended
Umbilical cord blood stem cell therapies used in the treatment of blood cancers are forging ahead, but it's an uphill struggle.
Nature Biotechnology (December 2005)
| Full Text |
Clone star admits lies over eggs
After a year and a half of denials, Woo Suk Hwang admitted last Thursday that his stem-cell research used eggs from paid donors and junior members of his team.
Nature (1 December 2005)
| Full Text |
Rocky future predicted for labs that rely on postdocs
Dependence on a temporary and largely foreign workforce is threatening the stability of biomedical research in the United States.
Nature (1 December 2005)
| Full Text |
News in brief
Australian report calls for relaxation of stem-cell laws
| Innovation act proposes big boost for US research
| Image of retina takes prize for visions of biology
| Cash infusion saves Estonian gene bank
| Prize winning homeopathy research is withdrawn
| Court ruling offers hope for California stem-cell project
| Sweden becomes home to neuroscience data centre
| NIH proposes grant cuts for young researchers
| Cash boost gives genetics institute a broader remit
| HapMap yields clues to human diseases
| Immunologist admits to falsifying data
| South Korea's stem cell star accused of ethics breach
| Disputed US stem-cell lines to be tested in Britain
| Germany focuses research on ageing population
News Features
Alcohol and science: The party gene
Siëlle Gramser discovers how yeast first opened the floodgates of intoxication.
Nature (21 December 2005)
| Full Text |
Merck opts for shake-up to clear drug pipeline
The failure of the painkiller Vioxx and a lack of new products leaves the world's third-largest drug company in the lurch.
Nature (21 December 2005)
| Full Text |
Nonsense mutations: Running the red light
A trial drug encourages cells to ignore the signs that stop them making faulty proteins. Sound dangerous? Claire Ainsworth discovers that it could be a cure for genetic disease.
Nature (8 December 2005)
| Full Text |
Stem cell therapy or snake oil?
Desperate patients are traveling abroad for dubious stem cell therapies. Monya Baker investigates the potential damage not only to human lives but to reputable stem cell research.
Nature Biotechnology (December 2005)
| Full Text |
Science in the web age: Joint efforts
Many scientists are reluctant to embrace the latest web tools that would allow them to communicate their ideas in new ways.
Nature (1 December 2005)
| Full Text |
Cell biology: Ion channels and stem cells
Ion channels, stem cells and cell signaling are the focus of intense interest in both cell biology and drug discovery. Pete Moore takes a look at what's on offer for the researcher.
Nature (1 December 2005)
| Full Text |
|
